News & Perspective

Sep 25, 2009

Sep 25, 2009

Biggest pandemic worry for business: absenteeism

(CIDRAP News) – Business officials who attended a conference this week on how the business world can cope with the H1N1 influenza pandemic said employee absenteeism was far and away their leading concern.

In live polling conducted during a conference plenary session, 81% of the attendees said their greatest concern about the pandemic was absenteeism. Only 13% said they were most worried about disruption of critical supply chains.

Sep 23, 2009

Sep 23, 2009

Business summit panelists stress practicality to slow flu spread

Sept 23, 2009 (CIDRAP News) – To mask or not to mask, hand washing versus hand sanitizers, how long to stay away from the workplace if sick with novel H1N1 influenza, tips for travel—these were some of the issues addressed in a panel discussion yesterday during a business preparedness summit in Minneapolis.

Jun 05, 2009

Jun 05, 2009

Obama seeks more funds for novel flu fight

(CIDRAP News) – President Barack Obama this week asked Congress for another $2 billion in supplemental funds to fight the novel H1N1 influenza epidemic, on top of $2 billion requested a month ago, and also proposed to tap federal economic stimulus funds for up to another $3.1 billion for the same purpose.

Meanwhile, public health advocates said even more may be needed if a nationwide H1N1 vaccination campaign is launched in the fall.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»